Skip to Content

Blue Spoon Consulting Publishes Strategy Innovation for Established Drug Brands

NEW YORK, NY October 26, 2009 – Blue Spoon Consulting Group, LLC, today published a strategy pharmaceutical companies can apply to reinvent growth for established drug brands. Addressing the total context of change reshaping the operating environment, the approach shifts the center of gravity in pharmaceutical brand management, focusing on market collaboration and novel linkages to create new health and business value. Available for download through the Blue Spoon Consulting website ( ), the strategic brief builds on the concept of ‘health ecosystem design’ introduced by Blue Spoon as a new model for competitive strategy, regionalization and employer initiatives, and account-based sales to integrated delivery networks.

Blue Spoon is a leading strategy and marketing innovation consultancy serving the global pharmaceutical, health products, and information technology industries. Blue Spoon has pioneered a methodology for market strategy defined in 21st-century terms, an approach that enables an evolutionary leap in solutions for growth and competitive advantage. The firm was the first to introduce ‘marketing ecosystems’ as a framework to synthesize strategy, media, content and distribution platforms for in-line products.1 Visit: .

# # #

1J.G. Singer, “Framing Brand Management for Marketing Ecosystems,” Journal of Business Strategy, 27, no. 5 (2006): 50-57.

380 Lexington Avenue, Suite 1700 New York, NY 10168

-- John G. Singer Managing Director Blue Spoon Consulting pioneering system-level competition

Phone: New York USA +917.538.4239

Posted: October 2009